An Artificial Microbiome Consortium Prevents Recurrence of Clostridioidesdifficile Infection: Paving the Way for Fecal Microbiota Transplantation 2.0
- PMID: 35525320
- DOI: 10.1053/j.gastro.2022.05.002
An Artificial Microbiome Consortium Prevents Recurrence of Clostridioidesdifficile Infection: Paving the Way for Fecal Microbiota Transplantation 2.0
Comment on
-
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.N Engl J Med. 2022 Jan 20;386(3):220-229. doi: 10.1056/NEJMoa2106516. N Engl J Med. 2022. PMID: 35045228 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
